Anal Cancer: Progress on Combined-Modality and Organ Preservation

被引：7
|
作者：
Chan, Emily [1 ]
Kachnic, Lisa A. [2 ]
Thomas, Charles R., Jr. [3 ,4 ]
机构：
[1] Vanderbilt Ingram Canc Ctr, Div Hematol Oncol, Dept Med, Nashville, TN USA
[2] Boston Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02118 USA
[3] OHSU Knight Canc Inst, Dept Radiat Med, Portland, OR USA
[4] OHSU Knight Canc Inst, Div Hematol Oncol, Dept Med, Portland, OR USA
来源：
CURRENT PROBLEMS IN CANCER | 2009年 / 33卷 / 05期
关键词：
SQUAMOUS-CELL CARCINOMA; HIV-POSITIVE PATIENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS DNA; EPIDERMOID CARCINOMA; COMBINED THERAPY; TREATMENT TOLERANCE; INFECTED PATIENTS; SALVAGE SURGERY; OUTCOMES;
D O I：
10.1016/j.currproblcancer.2009.10.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：302 / 326
页数：25
相关论文
共 50 条
  • [1] Anal Cancer: Progress on Combined-Modality and Organ Preservation Foreword
    Johnstone, Peter A. S.
    CURRENT PROBLEMS IN CANCER, 2009, 33 (05) : 301 - 301
  • [2] Organ preservation in muscle-invasve bladder cancer: combined-modality treatment
    Plasswilm, L.
    ONKOLOGIE, 2011, 34 : 91 - 91
  • [3] Preclinical Models of Anal Cancer Combined-Modality Therapy
    Johnson, Hillary R.
    Gunder, Laura C.
    Gillette, Amani
    Sleiman, Hana
    Rademacher, Brooks L.
    Meske, Louise M.
    Culberson, Wesley S.
    Micka, John A.
    Favreau, Peter
    Yao, Evan
    Matkowskyj, Kristina A.
    Skala, Melissa C.
    Carchman, Evie H.
    JOURNAL OF SURGICAL RESEARCH, 2024, 294 : 82 - 92
  • [4] Combined-modality treatment and organ preservation in bladder cancer -: Do molecular markers predict outcome?
    Weiss, C
    Rödel, F
    Wolf, I
    Papadopoulos, T
    Engehausen, DG
    Schrott, KM
    Sauer, R
    Rödel, C
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 (04) : 213 - 222
  • [5] Combined-Modality Treatment for Anal Cancer Current Strategies and Future Directions
    Fraunholz, Ingeborg
    Rabeneck, Daniela
    Weiss, Christian
    Roedel, Claus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 361 - 366
  • [6] Combined-modality treatment and selective organ preservation in invasive bladder cancer:: Long-term results
    Rödel, C
    Grabenbauer, GG
    Kühn, R
    Papadopoulos, T
    Dunst, J
    Meyer, M
    Schrott, KM
    Sauer, R
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) : 3061 - 3071
  • [7] Combined-modality therapy for esophageal cancer: Are we making progress?
    Gibson, MK
    Forastiere, AA
    CANCER JOURNAL, 2003, 9 (04): : 238 - 240
  • [8] Organ preservation in invasive bladder cancer: Partial-bladder radiation by brachytherapy - an alternative to cystectomy and combined-modality treatment?
    Weiss, C
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (06) : 353 - 354
  • [9] COMBINED-MODALITY THERAPY OF ESOPHAGEAL CANCER
    KELSEN, D
    BAINS, M
    HILARIS, B
    MARTINI, N
    SEMINARS IN ONCOLOGY, 1984, 11 (02) : 169 - 177
  • [10] Primary combined-modality therapy for esophageal cancer
    Minsky, Bruce D.
    ONCOLOGY-NEW YORK, 2006, 20 (05): : 497 - 505
12345